Franciele Hinterholz Knebel

Sequential liquid biopsies reveal dynamic alterations of EGFR driver mutations and indicate EGFR amplification as a new mechanism of resistance to osimertinib in NSCLC

Franciele Hinterholz Knebel, Fabiana Bettoni, Andrea Kazumi Shimada et al. · Lung Cancer · 2017 · 75 citations

Medicine, Molecular Biology, Molecular Genetics +13

Tryptamine and dimethyltryptamine inhibit indoleamine 2,3 dioxygenase and increase the tumor‐reactive effect of peripheral blood mononuclear cells

Melissa Cavalheiro Tourino, Edson Mendes de Oliveira, Luziane Potrich Bellé et al. · Cell Biochemistry and Function · 2013 · 58 citations · Full text

Medicine, Immunology, Pharmacology +9

Serum amyloid A is a growth factor for 3T3-L1 adipocytes, inhibits differentiation and promotes insulin resistance

Fabíola Branco Filippin-Monteiro, Edson Mendes de Oliveira, Silvana Sandri et al. · International Journal of Obesity · 2011 · 50 citations · Full text

Life Sciences, Cell Biology, Endocrinology +17

Serum Amyloid A in the Placenta and Its Role in Trophoblast Invasion

Silvana Sandri, Alexandre Urban Borbely, Isabella Rodrigues Fernandes et al. · PLoS ONE · 2014 · 47 citations · Full text

Life Sciences, Cell Biology, Immunology +15

Impressive response to dabrafenib, trametinib, and osimertinib in a metastatic EGFR-mutant/BRAF V600E lung adenocarcinoma patient

Maurício Fernando Silva Almeida Ribeiro, Franciele Hinterholz Knebel, Fabiana Bettoni et al. · npj Precision Oncology · 2021 · 42 citations · Full text

Medicine, Oncology, Pharmacology +16